Registered entities
APEXIMMUNE THERAPEUTICS INC
Reg. No. 813648439United States
Investor mix
8 investors on record; lead investors include Pharmaessentia Corporation.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 38% |
| Private equity | 1 | 13% |
| Other / undisclosed | 4 | 50% |